A new study has found that a drug originally developed to treat diabetes could significantly improve the brains of those suffering from Alzheimer's disease.
Luxturna is the first gene therapy approved by the Food and Drug Administration that treats a medical condition -- in this case, blindness -- by fixing a mistake in a patient's DNA.